A new study explored molecules carried within blood exosomes to see if changes in fat metabolism contribute to lupus.

The SLE and LN market offers opportunities with the launch of 10 late-stage pipeline drugs improving safety and efficacy, contrasting with the current generic treatments. However, growth is challenged ...

A new study found that low levels of 25-Hydroxyvitamin D levels are associated with significantly higher mortality and ...

Autoimmune diseases affect approximately 5 to 10% of the global population, with increasing prevalence over recent decades.

Belimumab Monotherapy Matches Combination Therapy in SLE Patients with systemic lupus erythematosus who receive belimumab monotherapy show comparable remission rates and disease control to those who ...

Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight The SLE clinical trial analysis report delivers ...

Investigators studied GLP-1 receptor agonist use and renal and inflammatory outcomes among patients with systemic lupus erythematosus and type 2 diabetes mellitus.

The immune system is designed to protect us against viruses and bacteria. In autoimmune diseases, however, the immune system ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Maureen McMahon, ...